 Neurocrine Biosciences, Inc. NASDAQ:NBIX Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Todd Tushla - Vice President of Investor Relations Kevin Gorman - Chief Executive Officer Matt Abernethy - Chief Financial Officer Eiry Roberts - Chief Medical Officer Eric Benevich - Chief Commercial Officer Kyle Gano - Chief Business Development and Strategy Officer Conference Call Participants Phil Nadeau - Cowen Company Leonid Timashev - RBC Capital Markets Paul Matteis - Stifel Tazeen Ahmad - Bank of America Neena Bitritto-Garg - Citi Jay Olson - Oppenheimer Carter Gould - Barclays Anupam Rama - JPMorgan Brian Skorney - Baird Chris Shibutani - Goldman Sachs Myles Minter - William Blair Danielle Brill - Raymond James Laura Chico - Wedbush Marc Goodman - SVB David Amsellem - Piper Sandler Yatin Suneja - Guggenheim Partners Operator Good day, everyone. And welcome to todays Neurocrine Biosciences Reports Second Quarter Results Operator Instructions. 